Current stock page

Catalysts

ABBV Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareDrug Manufacturers - GeneralScore data as of Sep 4, 2026

ABBV

Catalysts
AbbVie Inc.
Healthcare· Drug Manufacturers - General
AIQ Score
NeutralAIQ Edge 5/10
Low Priority
In Line With Peers
Score data as of Sep 4, 2026
Last price
$256.46
-$3.75 (-1.44%)
Latest market quote
Momentum65
Value36
Quality60
Risk Resilience44
Sentiment86
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Oct 30, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 52/100

Momentum 65/100 and sentiment 86/100 before the next covered event.

Recent coverage
4 articles

Updated Sep 6, 2026 · Sentiment 44.93%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 65/100AIQ Edge 5/10 In Line With Peers
Beat rate
88%
7 of 8 reported periods
Average surprise
-0.9%
Across covered historical reports
Latest result
+1.1%
Jul 31, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Jul 31, 2026$3.61$3.65+1.1%$16.8B$16.99B
Apr 29, 2026$2.59$2.65+2.3%$14.72B$15B
Feb 4, 2026$2.65$2.71+2.3%$16.41B$16.62B
Oct 31, 2025$1.77$1.86+5.1%$15.59B$15.78B
Jul 31, 2025$2.88$2.97+3.1%$15.03B$15.42B
Apr 25, 2025$2.38$2.46+3.4%$12.93B$13.34B
Jan 31, 2025$2.98$2.16-27.5%$14.83B$15.1B
Oct 30, 2024$2.92$3.00+2.7%$14.28B$14.46B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
25
Buy
5
Hold
1
Sell
12-month analyst target
$279.54
+9.00% versus current price
Based on 13 analyst observations. Targets are estimates, not predictions.
Low target
$235.00
-8.37% vs latest price
Average target
$279.54
+9.00% vs latest price
High target
$303.00
+18.15% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateOct 30, 2026

Next known earnings or reporting date.

EPS estimate$3.86

Current analyst expectation for the upcoming report.

Revenue estimate$17.31B

Current analyst expectation for the upcoming report.

Sentiment score86

News pressure around the setup.

Momentum score65

Where event reaction would show up first.

AIQ score52/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
13
Average target
$279.54
Target upside
9.00%
Target range
$235.00 - $303.00
90-day revisions
3

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
4
Neutral
0
Negative
0
insidermonkey.com · Sep 4, 2026

AbbVie (ABBV)’s Blood Cancer Success Adds Weight to its Pipeline Story

AbbVie Inc.

zacks.com · Sep 3, 2026

Top Analyst Reports for Amazon, AbbVie & Alibaba

Amazon, AbbVie and Alibaba face contrasting growth drivers and challenges, from AI investment and drug launches to costly spending cycles.

gurufocus.com · Sep 3, 2026

AbbVie (ABBV) Completes Acquisition of Apogee Therapeutics

AbbVie Inc. (ABBV) announced on September 3, 2026, the successful completion of its acquisition of Apogee Therapeutics, Inc. The announcement was made through

gurufocus.com · Sep 3, 2026

ABBV Looks 18.1% Overvalued on GF Value™ Amid Dividend Strength

On September 03, 2026, AbbVie Inc (NYSE: ABBV) announced promising results from its Phase 3 CERVINO trial of etentamig, an experimental multiple myeloma treatme

Open full news and sentiment

ABBV Catalysts FAQ

What are the next catalysts for ABBV stock?

ABBV's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move ABBV stock?

Upcoming events that could move ABBV include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could ABBV's next earnings report affect the stock?

ABBV's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive ABBV stock higher?

ABBV could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt ABBV stock?

ABBV could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.